P0938 Corticosteroid and opiate use in Inflammatory Bowel Disease, 25 years after the Crohn’s Therapy, Resource, Evaluation, and Assessment Tool (TREAT) registry was established
Brigid Pinnuck(Royal Adelaide Hospital), Jane M. Andrews(Health Net), Michael Schultz, Gabrielle Wark(St Vincent's Hospital Melbourne), Kate D. Lynch(Royal Adelaide Hospital), Ian C. Lawrance(The University of Western Australia), Joseph L. Pipicella(Ingham Institute), Susan J. Connor(Liverpool Hospital), Shoma Dutt(The University of Sydney), Alistair Forbes(University of Otago), Wen‐Yu Su(Liverpool Hospital), L Brett(Logan Hospital), Gregor Walker(The University of Queensland), Huan Su(Weihai Science and Technology Bureau), M Archdiacono(St Vincent's Hospital Sydney), W.J. Wilson(Commonwealth Scientific and Industrial Research Organisation)
Cited by 0
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Maintenance Therapy with Certolizumab Pegol for Crohn's Disease
|New England Journal of Medicine|2007|1.1k
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
|The Lancet|2015|779
The Upper Atmosphere Research Satellite microwave limb sounder instrument
|Journal of Geophysical Research Atmospheres|1993|307